Clinical TrialMay 14, 2026, 08:11 AM
Apyx Medical Announces Positive Renuvion® Clinical Study Results
AI Summary
Apyx Medical Corporation announced the publication of a new retrospective investigator-initiated study in Plastic and Reconstructive Surgery - Global Open. The study evaluated patient-reported outcomes following liposuction with and without helium plasma radiofrequency (Renuvion®). Results showed statistically significant improvements in patient satisfaction with abdominal appearance and excess skin, along with lower rates of abdominoplasty and surgical revisions, while maintaining comparable complication rates.
Key Highlights
- Patients treated with Renuvion reported statistically higher satisfaction with reduced appearance of excess skin (Body-Q score 87.8 vs. 73.8; p=0.03).
- Satisfaction with abdominal appearance was statistically higher among patients who did not undergo abdominoplasty (68.8 vs. 45.0; p=0.039).
- The rate of patients requiring abdominoplasty was over 50% lower in the Renuvion group (30.0% vs. 67.1%).
- Revision rates were significantly lower in the Renuvion group (12.0% vs. 37.5%; p=0.038).
- Complication rates remained similar between groups (2.5% vs. 2.7%).
Price Impact
More from APYX
More in Clinical Trial